Answers are grounded in this paper and cite their sources.
Identification of characteristics associated with active disease in juvenile idiopathic arthritis (JIA) could inform early disease treatment strategies. This study evaluated characteristics associated with active disease at 12 and 24 months after JIA diagnosis in the era in which biologic disease-modifying antirheumatic drugs (DMARDs) became available for JIA.
No takes yet. Share an insight, caveat, or question.
Balay‐Dustrude et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: